About
Sonic Incytes develops Velacur ONE, a point-of-care AI-guided ultrasound elastography device that non-invasively measures liver elasticity and attenuation to assess chronic liver diseases such as MASLD and MASH, with FDA 510(k) clearance and clinical validation.
Explore Sonic Incytes's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.